ROSSARI BIOTECH LTD.

NSE : ROSSARIBSE : 543213ISIN CODE : INE02A801020Industry : ChemicalsHouse : Private
BSE759.00-0.8 (-0.11 %)
PREV CLOSE ( ) 759.80
OPEN PRICE ( ) 756.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2220
TODAY'S LOW / HIGH ( )756.05 770.00
52 WK LOW / HIGH ( )665.25 903.45
NSE761.600.75 (+0.1 %)
PREV CLOSE( ) 760.85
OPEN PRICE ( ) 762.95
BID PRICE (QTY) 761.60 (25)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30099
TODAY'S LOW / HIGH( ) 755.20 770.20
52 WK LOW / HIGH ( )656.95 903.85
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax1442.191362.751068.38880.59633.92
Adjustment831.49552.54205.82199.86167.59
Changes In working Capital-271.97-1120.47-483.05-310.68113.94
Cash Flow after changes in Working Capital2001.71794.82791.15769.77915.45
Cash Flow from Operating Activities1523.94293.58477.67568.29711.77
Cash Flow from Investing Activities-1808.94-2988.79-371.79-1903.01-364.22
Cash Flow from Financing Activities608.552917.90-245.921569.43-291.50
Net Cash Inflow / Outflow323.55222.69-140.04234.7156.05
Opening Cash & Cash Equivalents374.77152.08292.1157.426.25
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANA0.01-0.02-4.88
Closing Cash & Cash Equivalent698.32374.77152.08292.1157.42

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.